Butt BP, Sorbye H, Ladekarl M, Stokmo HL, Lothe IMB, Fawad H, Tabaksblat EM, Revheim ME, Dybdahl B, Couvelard A, Perren A, Hjortland GO(2026) Efficacy of FOLFIRINOX in digestive neuroendocrine carcinoma J Neuroendocrinol, 38(4), e70168 DOI 10.1111/jne.70168, PubMed 41911950
Astrup GL, Siksjø MK, Aass N, Alves G, Brønnick KK, Hjermstad MJ, Kaasa S, Karlsson AT, Landrø NI, Tysnes OB, Seierstad T, Yri OE(2025) Cognitive function in long-term survivors after treatment for brain metastases compared with normative samples Neurooncol Pract, 13(1), 178-188 DOI 10.1093/nop/npaf083, PubMed 41798131
Brandal SHB, Mo T, Fangberget A, Nilsen LB, Geier OM, Bjørndal H, Holmen MM, Engebråten O, Garred Ø, Hole KH, Seierstad T(2026) MRI for Predicting Response and 10-Year Outcome of Neoadjuvant Chemotherapy with or Without Additional Bevacizumab Treatment in HER2-Negative Breast Cancer Cancers (Basel), 18(3) DOI 10.3390/cancers18030393, PubMed 41681863